Wuxi AppTec Co Ltd (WUXAY)
5.45
+0.18
(+3.42%)
USD |
OTCM |
May 16, 16:00
Wuxi AppTec Accounts Receivable (Quarterly): 979.27M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 979.27M |
December 31, 2023 | 1.115B |
September 30, 2023 | 1.042B |
June 30, 2023 | 1.076B |
June 30, 2023 | 1.076B |
March 31, 2023 | 962.70M |
December 31, 2022 | 865.71M |
September 30, 2022 | 851.98M |
June 30, 2022 | 950.69M |
June 30, 2022 | 950.69M |
March 31, 2022 | 1.005B |
December 31, 2021 | 724.74M |
September 30, 2021 | 695.74M |
June 30, 2021 | 644.88M |
June 30, 2021 | 644.88M |
March 31, 2021 | 588.50M |
December 31, 2020 | 560.94M |
Date | Value |
---|---|
September 30, 2020 | 528.75M |
June 30, 2020 | 466.89M |
June 30, 2020 | 466.89M |
March 31, 2020 | 394.26M |
December 31, 2019 | 419.70M |
September 30, 2019 | 418.61M |
June 30, 2019 | 363.48M |
June 30, 2019 | 363.48M |
March 31, 2019 | 326.59M |
December 31, 2018 | 289.97M |
September 30, 2018 | 272.28M |
June 30, 2018 | 286.53M |
June 30, 2018 | 286.53M |
March 31, 2018 | 270.88M |
December 31, 2017 | 215.76M |
September 30, 2017 | 236.18M |
March 31, 2017 | 213.87M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
363.48M
Minimum
Jun 2019
1.115B
Maximum
Dec 2023
726.27M
Average
695.74M
Median
Sep 2021
Accounts Receivable (Quarterly) Benchmarks
WuXi Biologics (Cayman) Inc | 797.57M |
Sinovac Biotech Ltd | 426.01M |
CASI Pharmaceuticals Inc | 9.551M |
Zai Lab Ltd | 60.42M |
Gracell Biotechnologies Inc (DELISTED) | -- |